OpanaER (Endo Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Opana drug offered from Endo Pharmaceuticals, Inc.. This Full Opioid Agonists [MoA],Opioid Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Endo Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | oxymorphone hydrochloride |
| SUBSTANCE NAME: | OXYMORPHONE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-03-20 |
| END MARKETING DATE: | 2020-02-01 |
Opana ER HUMAN PRESCRIPTION DRUG Details:
| Item Description | Opana ER from Endo Pharmaceuticals, Inc. |
| LABELER NAME: | Endo Pharmaceuticals, Inc. |
| DEA SCHEDULE: | CII
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2012-03-20 |
| END MARKETING DATE: | 2020-02-01 |
| PRODUCT ID: | 63481-812_ee1e2e27-7455-429d-99d1-e5962ac1eb2c |
| PRODUCT NDC: | 63481-812 |
| APPLICATION NUMBER: | NDA201655 |
Other OXYMORPHONE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
